FIELD: medicine, dermatology, pharmacy. SUBSTANCE: invention relates to composition used for stimulation of skin melanin pigment and designated for treatment of vitiligo and can be used for treatment of any skin depigmentation. Method for preparing the composition used for stimulation of melanin pigment synthesis involves the following stages: grinding placenta tissue, maceration with ethanol, filtration, treatment with saturated solution of benzoic acid in ethanol and distilled water and with acetone also, dissolving the component in alcohol comprising from 0.2 to 4.0 mg/ml of calcium chloride, and filtration through column with Sephadex. Fractions corresponding to the second protein peak from 20 to 150 g/ml are collected, lyophilized and the component is dissolved in 50% spirituous solution containing CaCl2 taken in the concentration from 0.2 to 4.0 mg/ml. The composition used for stimulation of melanin pigment synthesis comprises 50% human placenta extract. The end component can be prepared by easy method, its useful in application, it doesn't exhibit toxic effect, it recoveries skin pigmentation rapidly after onset of treatment and ceasing in its application doesn't result to relapses. EFFECT: improved preparing method, valuable medicinal properties of composition. 4 cl, 5 tbl, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION FOR VITILIGO TREATMENT | 2004 |
|
RU2321397C2 |
METHOD FOR TREATING THE CASES OF VITILIGO | 2002 |
|
RU2209098C1 |
METHOD OF PRODUCING ALPHA-LYPOPROTEIN FROM HUMAN PLACENTA | 0 |
|
SU1475476A3 |
METHOD FOR TREATING RESISTANT FORMS OF VITILIGO | 2021 |
|
RU2778105C1 |
METHOD OF TREATING VITILIGO | 2014 |
|
RU2566201C1 |
METHOD FOR THE TREATMENT OF NON-SEGMENTAL VITILIGO WITH CONCOMITANT ACNE DIAGNOSIS | 2020 |
|
RU2745188C1 |
METHOD FOR VITILIGO TREATMENT | 2017 |
|
RU2648757C1 |
METHOD OF PHOTOCHEMOTHERAPY OF VITILIGO | 2018 |
|
RU2698871C1 |
APPLICATION OF AT LEAST ONE PLANT EXTRACT OF CHRYSANTHEMUM GENUS FOR STIMULATION OF SKIN AND/OR HAIR PIGMENTATION | 1998 |
|
RU2197945C2 |
USE OF PREPARATION LAENNEK FOR TREATING A DISEASE, ASSOCIATED WITH IMPAIRED IMMUNITY, WHICH IS A CHRONIC RECURRENT HERPES, ATOPIC DERMATITIS OR PSORIASIS | 2015 |
|
RU2599038C1 |
Authors
Dates
2004-03-20—Published
1999-07-28—Filed